Prehyp 2023

Prehyp 2023

Dear colleagues and friends,

It is our pleasure to invite you to participate in The 9th International Conference on Prehypertension, Hypertension & the Cardio Metabolic Syndrome, which will take place in Zagreb, Croatia - October 18-22, 2023.

In this conference we are going to discuss all aspects of hypertension and other CV risk factors, starting from prehypertension and other early metabolic derangements because early diagnosis and intervention is crucial. New diagnostic procedures will also be elaborated.

Importance of lifestyle change, proper blood pressure measurements with the focus on newly developed methods will be part of our conference.

As we are at the new dawn of drug and intervention therapy for patients with hypertension, cardiovascular risk factors and especially the
cardiometabolic syndrome, as well as for kidney patients and those with heart failure, important sessions will focus on these new aspects.

​Nurses, pharmacists, social workers, dieticians, and other allied professionals are essential and should participate in this fight for wellness in
healthy and populations at risk. All these together with the physicians should cooperate for maximal success in fighting the development of disease.

​New technologies, both diagnostic and therapeutic, like Digital technology are essential for diagnosis and optimal treatment and those will be discussed thoroughly.

​This is the year of new ESH guidelines on the management of hypertension.

Several round table sessions will be devoted to discussions of this desirable awaited document. However, we will discuss also the controversial parts, about future potential missing topics and new issues which should be precisely defined.

​As we did last year, this year we will organize several "hands-on" workshops, in which experts will guide younger colleagues on many important practical aspects of end organ evaluation.

​"Meet the expert” sessions were very well attended last year, during all coffee breaks, burning issues of cardiorenal and metabolic continuum will be discussed.

​The purpose of our meeting is to discuss in depth new mechanisms of cardiovascular and renal damage, novel methods of diagnosis, leading to new therapeutic approaches.

​We cordially invite you to this conference with distinguished speakers coming from all continents (apart from Antarctica).

​You will enjoy with us the beauty of hypertension and cardiometabolic disase,
but also, friendship and our common commitment to improve lives of our patients.

Best regards, 

Bojan Jelakovć and Reuven Zimlichman